Tapewire

Nasdaq · USD

CRSP

CRISPR Therapeutics AG

Export transactions ↓
Tapewire entity
3852
SEC CIK
0001674416
Parsed reports
491

Last 12 months

Inside the activity.

0 purchase rows · 27 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202503
Jan 202607
Feb 202602
Mar 2026010
Apr 202600
May 202601
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202602

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 29, 2023 Filed Mar 31, 2023 21:49 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 5,281 $44.78 $236,506.42
Disclosure

SEC source: 0001209191-23-021911 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 387,377

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.63 to $44.97, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 29, 2023 Filed Mar 31, 2023 21:49 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 19,719 $44.37 $874,997.10
Disclosure

SEC source: 0001209191-23-021911 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 392,658

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.63 to $44.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 29, 2023 Filed Mar 31, 2023 21:49 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $19.12 $478,000.00
Disclosure

SEC source: 0001209191-23-021911 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 412,377

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 14, 2023 Filed Mar 14, 2023 21:50 UTC
Prasad RajuChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 100,000 $0.00 Strike: $45.15 $0.00
Disclosure

SEC source: 0001209191-23-018571 · doc4.xml · derivative · entry 2

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Shares · 100,000 shares

Expires 2033-03-14

F3 · derivative.exercise_date: This option was granted on March 14, 2023 with respect to 100,000 Common Shares, with 25% of the shares vesting on March 14, 2024 and the remaining shares vesting on each monthly anniversary thereafter for a period of 36 months.

Read SEC document
March 14, 2023 Filed Mar 14, 2023 21:50 UTC
Prasad RajuChief Financial Officer
GrantRestricted Stock Units · Derivative 40,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018571 · doc4.xml · derivative · entry 1

Prasad Raju · CIK 0001968317 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Shares · 40,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · derivative.exercise_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027.

F2 · derivative.expiration_date: This restricted stock unit award was granted on March 14, 2023 with respect to 40,000 Common Shares, with (i) one quarter of the shares vesting on March 14, 2024, (ii) one quarter of the shares vesting on March 14, 2025, (iii) one quarter of the shares vesting on March 14, 2026, and (iv) one quarter of the shares vesting on March 14, 2027.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Tax withholdingCommon Shares 1,022 $43.22 $44,170.84
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · nonDerivative · entry 4

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,844

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Tax withholdingCommon Shares 1,283 $43.22 $55,451.26
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · nonDerivative · entry 2

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 53,616

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Tax withholdingCommon Shares 4,086 $43.22 $176,596.92
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 387,377

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 13, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Tax withholdingCommon Shares 5,358 $43.22 $231,572.76
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,463

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
March 11, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 2,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · derivative · entry 8

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,500

Underlying: Common Shares · 2,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F6 · derivative.exercise_date: This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025.

F6 · derivative.expiration_date: This restricted stock unit award was granted on March 11, 2021 with respect to 9,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025.

Read SEC document
March 11, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon Shares 2,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · nonDerivative · entry 3

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,866

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 11, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 9,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · derivative · entry 8

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,000

Underlying: Common Shares · 9,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F6 · derivative.exercise_date: This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025.

F6 · derivative.expiration_date: This restricted stock unit award was granted on March 11, 2021 with respect to 36,000 Common Shares, with (i) one quarter of the shares vesting on March 11, 2022, (ii) one quarter of the shares vesting on March 11, 2023, (iii) one quarter of the shares vesting on March 11, 2024, and (iv) one quarter of the shares vesting on March 11, 2025.

Read SEC document
March 11, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 9,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 391,463

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
GrantRestricted Stock Units · Derivative 22,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · derivative · entry 7

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Shares · 22,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F5 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

F5 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
GrantStock Option (Right to Buy) · Derivative 40,000 $0.00 Strike: $43.22 $0.00
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · derivative · entry 6

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Shares · 40,000 shares

Expires 2033-03-10

F4 · derivative.exercise_date: This option was granted on March 10, 2023 with respect to 40,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 2,833 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · derivative · entry 5

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 2,833 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2020 with respect to 8,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:45 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon Shares 2,833 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018564 · doc4.xml · nonDerivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,899

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GrantRestricted Stock Units · Derivative 77,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · derivative · entry 7

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,000

Underlying: Common Shares · 77,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F5 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

F5 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2023 with respect to 77,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 188,000 $0.00 Strike: $43.22 $0.00
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · derivative · entry 6

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 188,000

Underlying: Common Shares · 188,000 shares

Expires 2033-03-10

F4 · derivative.exercise_date: This option was granted on March 10, 2023 with respect to 188,000 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 11,833 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · derivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 11,833 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2020 with respect to 35,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2020 with respect to 35,500 Common Shares, with (i) one third of the shares vesting on March 10, 2021, (ii) one third of the shares vesting on March 10, 2022, and (iii) one third of the shares vesting on March 10, 2023.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:47 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 11,833 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-018566 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 387,821

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:44 UTC
Morrow Phuong KhanhChief Medical Officer
GrantRestricted Stock Units · Derivative 22,000 $0.00 $0.00
Disclosure

SEC source: 0001209191-23-018561 · doc4.xml · derivative · entry 2

Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 22,000

Underlying: Common Shares · 22,000 shares

Expires not disclosed

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

F3 · derivative.expiration_date: This restricted stock unit award was granted on March 10, 2023 with respect to 22,000 Common Shares, with (i) one quarter of the shares vesting on March 10, 2024, (ii) one quarter of the shares vesting on March 10, 2025, (iii) one quarter of the shares vesting on March 10, 2026, and (iv) one quarter of the shares vesting on March 10, 2027.

Read SEC document
March 10, 2023 Filed Mar 14, 2023 21:44 UTC
Morrow Phuong KhanhChief Medical Officer
GrantStock Option (Right to Buy) · Derivative 44,620 $0.00 Strike: $43.22 $0.00
Disclosure

SEC source: 0001209191-23-018561 · doc4.xml · derivative · entry 1

Morrow Phuong Khanh · CIK 0001928989 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,620

Underlying: Common Shares · 44,620 shares

Expires 2033-03-10

F1 · derivative.exercise_date: This option was granted on March 10, 2023 with respect to 44,620 Common Shares. 100% of the shares will vest in 48 equal monthly installments, with the first vesting date of April 10, 2023.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:11 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-23-014273 · doc4.xml · derivative · entry 5

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,582

Underlying: Common Shares · 25,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:11 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 1,100 $49.20 $54,118.46
Disclosure

SEC source: 0001209191-23-014273 · doc4.xml · nonDerivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,988

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.1350 to $49.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:11 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 13,720 $48.57 $666,414.70
Disclosure

SEC source: 0001209191-23-014273 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 377,088

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $48.13 to $49.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:11 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 10,180 $47.71 $485,710.20
Disclosure

SEC source: 0001209191-23-014273 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 390,808

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.13 to $48.07, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
February 27, 2023 Filed Mar 1, 2023 23:11 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $19.12 $478,000.00
Disclosure

SEC source: 0001209191-23-014273 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 400,988

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 22:41 UTC
Smith BrendanChief Financial Officer
Tax withholdingCommon Shares 1,392 $48.26 $67,177.92
Disclosure

SEC source: 0001209191-23-011790 · doc4.xml · nonDerivative · entry 2

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,072

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 22:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Tax withholdingCommon Shares 6,373 $48.26 $307,560.98
Disclosure

SEC source: 0001209191-23-011782 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 375,988

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 22:35 UTC
KASINGER JAMES R.General Counsel and Secretary
Tax withholdingCommon Shares 1,950 $48.26 $94,107.00
Disclosure

SEC source: 0001209191-23-011777 · doc4.xml · nonDerivative · entry 2

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,066

F2 · shares: Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
February 18, 2023 Filed Feb 22, 2023 22:41 UTC
Smith BrendanChief Financial Officer
Exercise / conversionRestricted Stock Units · Derivative 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-011790 · doc4.xml · derivative · entry 3

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,475

Underlying: Common Shares · 3,825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

Read SEC document
February 18, 2023 Filed Feb 22, 2023 22:41 UTC
Smith BrendanChief Financial Officer
Exercise / conversionCommon Shares 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-011790 · doc4.xml · nonDerivative · entry 1

Smith Brendan · CIK 0001857492 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,464

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
February 18, 2023 Filed Feb 22, 2023 22:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 13,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-011782 · doc4.xml · derivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 39,750

Underlying: Common Shares · 13,250 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 53,000 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

Read SEC document
February 18, 2023 Filed Feb 22, 2023 22:38 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 13,250 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-011782 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 382,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
February 18, 2023 Filed Feb 22, 2023 22:35 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionRestricted Stock Units · Derivative 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-011777 · doc4.xml · derivative · entry 3

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,475

Underlying: Common Shares · 3,825 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F3 · derivative.exercise_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

F3 · derivative.expiration_date: This restricted stock unit award was granted on February 18, 2022 with respect to 15,300 Common Shares, with (i) one quarter of the shares vesting on February 18, 2023, (ii) one quarter of the shares vesting on February 18, 2024, (iii) one quarter of the shares vesting on February 18, 2025, and (iv) one quarter of the shares vesting on February 18, 2026.

Read SEC document
February 18, 2023 Filed Feb 22, 2023 22:35 UTC
KASINGER JAMES R.General Counsel and Secretary
Exercise / conversionCommon Shares 3,825 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-23-011777 · doc4.xml · nonDerivative · entry 1

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:34 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-23-005769 · doc4.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 179,582

Underlying: Common Shares · 25,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:34 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 23,200 $51.54 $1,195,711.76
Disclosure

SEC source: 0001209191-23-005769 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,111

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.02 to $51.92, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:34 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 1,800 $50.60 $91,085.76
Disclosure

SEC source: 0001209191-23-005769 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 392,311

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.02 to $50.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
January 27, 2023 Filed Jan 31, 2023 22:34 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $19.12 $478,000.00
Disclosure

SEC source: 0001209191-23-005769 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 22:33 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $19.12 $0.00
Disclosure

SEC source: 0001209191-22-063026 · doc4.xml · derivative · entry 4

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 204,582

Underlying: Common Shares · 25,000 shares

Expires 2027-12-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: This option was granted on December 1, 2017 with respect to 260,000 Common Shares with 100% of the shares vesting in 48 equal monthly installments beginning January 1, 2018.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 22:33 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 4,634 $41.45 $192,100.62
Disclosure

SEC source: 0001209191-22-063026 · doc4.xml · nonDerivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,111

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.23 to $41.87, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 22:33 UTC
Kulkarni SamarthDirector · Chief Executive Officer
SaleCommon Shares 20,366 $40.81 $831,189.41
Disclosure

SEC source: 0001209191-22-063026 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,745

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.22 to $41.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
December 28, 2022 Filed Dec 30, 2022 22:33 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 25,000 $19.12 $478,000.00
Disclosure

SEC source: 0001209191-22-063026 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 394,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 06, 2022 Filed Dec 8, 2022 22:35 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 58,233 $0.00 Strike: $1.81 $0.00
Disclosure

SEC source: 0001209191-22-060387 · doc4.xml · derivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 58,233 shares

Expires 2025-09-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: This option was granted on September 10, 2015 with respect to 321,712 Common Shares with 120,640 of the shares vested on August 1, 2016, the first anniversary of employment commencement, and the remainder vested in equal 36 monthly installments thereafter.

Read SEC document
December 06, 2022 Filed Dec 8, 2022 22:35 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionCommon Shares 58,233 $1.81 $105,401.73
Disclosure

SEC source: 0001209191-22-060387 · doc4.xml · nonDerivative · entry 1

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 369,111

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 22:49 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Tax withholdingCommon Shares 19,401 $52.26 $1,013,896.26
Disclosure

SEC source: 0001209191-22-060093 · doc4.xml · nonDerivative · entry 2

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 310,878

F3 · kind: On December 3, 2019, the reporting person was granted 120,000 restricted stock units. On December 3, 2022, 40,000 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
December 05, 2022 Filed Dec 6, 2022 22:47 UTC
KASINGER JAMES R.General Counsel and Secretary
Tax withholdingCommon Shares 3,234 $52.26 $169,008.84
Disclosure

SEC source: 0001209191-22-060090 · doc4.xml · nonDerivative · entry 2

KASINGER JAMES R. · CIK 0001708172 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,191

F4 · kind: On December 3, 2019, the reporting person was granted 20,000 restricted stock units. On December 3, 2022, 6,667 restricted stock units vested. Amount reported represents the number of shares required to be sold by the reporting person to cover the tax withholding obligation in connection with the vesting of these restricted stock units. This sale is mandated by the Company's RSU Settlement Policy to fund the tax withholding obligation and does not represent a discretionary trade by the reporting person.

Read SEC document
December 03, 2022 Filed Dec 6, 2022 22:49 UTC
Kulkarni SamarthDirector · Chief Executive Officer
Exercise / conversionRestricted Stock Units · Derivative 40,000 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-060093 · doc4.xml · derivative · entry 3

Kulkarni Samarth · CIK 0001682019 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Shares · 40,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F2 · price: Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.

F1 · derivative.exercise_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.

F1 · derivative.expiration_date: The restricted stock units shall vest as follows: two-thirds of the grant shall vest on December 3, 2021 and the remaining one-third shall vest on December 3, 2022.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.